المؤلفون: Le TK; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Brown I; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Goldberg R; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Taylor MT; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Deng J; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Parthasarathy V; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Bordeaux ZA; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina, USA., Alphonse MP; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Kwatra MM; Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina, USA., Naranbhai V; Department of Oncology, Mass General Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA; Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Gusev A; Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Alhariri J; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., LeBoeuf NR; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA; Department of Cutaneous Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Reynolds KL; Division of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Cappelli LC; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Naidoo J; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA., Brahmer JR; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; The Bloomberg-Kimmel Institute for Cancer Immunotherapy, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA., Kang S; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Semenov YR; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA., Kwatra SG; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Electronic address: skwatra1@jhmi.edu.

المصدر: The Journal of investigative dermatology [J Invest Dermatol] 2022 Nov; Vol. 142 (11), pp. 2896-2908.e4. Date of Electronic Publication: 2022 May 20.

نوع المنشور: Observational Study; Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1747 (Electronic) Linking ISSN: 0022202X NLM ISO Abbreviation: J Invest Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Stevens-Johnson Syndrome*/etiology , Stevens-Johnson Syndrome*/complications , Pemphigoid, Bullous* , Vitiligo*/complications , Drug Eruptions*/epidemiology , Drug Eruptions*/etiology , Erythema Multiforme*/complications , Eczema*/complications, Humans ; Pharmacovigilance ; Immune Checkpoint Inhibitors/adverse effects